Clinical trial
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in…
NCT00254202 · Vanda Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00254202 |
|---|---|
| Title | Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia |
| Official title | A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Iloperidone in Schizophrenic Patients in Acute Exacerbation Followed by a Long-term Treatment Phase. |
| Lead sponsor | Vanda Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Iloperidone, Ziprasidone, Placebo |
| Enrollment | 593 |
| Start date | Nov 18, 2005 |
| Primary completion | Sep 26, 2006 |
| Completion | Mar 21, 2007 |
| First posted | Nov 15, 2005 |
| Last update posted | Dec 13, 2024 |
| Countries | India, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: